6KY0

Crystal structural of active-site human glutathione-specific gamma-glutamylcyclotransferase 2(ChaC2) mutant with Glutamate 74 replaced by Glutamine

External Resource: Annotation

Domain Annotation: ECOD Classification
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	PF04752	e6ky0A1	A: a+b two layers	X: BtrG-like (Pfam 03674) (From Topology)	H: BtrG-like (Pfam 03674) (From Topology)	T: BtrG-like (Pfam 03674)	F: PF04752	ECOD (1.6)
B	PF04752	e6ky0B1	A: a+b two layers	X: BtrG-like (Pfam 03674) (From Topology)	H: BtrG-like (Pfam 03674) (From Topology)	T: BtrG-like (Pfam 03674)	F: PF04752	ECOD (1.6)
C	PF04752	e6ky0C1	A: a+b two layers	X: BtrG-like (Pfam 03674) (From Topology)	H: BtrG-like (Pfam 03674) (From Topology)	T: BtrG-like (Pfam 03674)	F: PF04752	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C	PF04752	ChaC-like protein (ChaC)	ChaC-like protein	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C	Glutathione-specific gamma-glutamylcyclotransferase 2	amidine-lyase activity glutathione specific gamma-glutamylcyclotransferase activity lyase activity catalytic activity carbon-nitrogen lyase activity gamma-glutamylcyclotransferase activity	glutathione metabolic process organonitrogen compound metabolic process cellular biosynthetic process cellular metabolic process organonitrogen compound biosynthetic process amide biosynthetic process cellular modified amino acid metabolic process sulfur compound biosynthetic process organic substance metabolic process biosynthetic process peptide biosynthetic process cellular modified amino acid biosynthetic process glutathione biosynthetic process organic substance biosynthetic process glutathione metabolic process organonitrogen compound metabolic process cellular biosynthetic process cellular metabolic process organonitrogen compound biosynthetic process amide biosynthetic process cellular modified amino acid metabolic process sulfur compound biosynthetic process organic substance metabolic process biosynthetic process peptide biosynthetic process cellular modified amino acid biosynthetic process glutathione biosynthetic process organic substance biosynthetic process metabolic process sulfur compound metabolic process cellular process amide metabolic process nonribosomal peptide biosynthetic process peptide metabolic process organonitrogen compound catabolic process catabolic process cellular catabolic process sulfur compound catabolic process glutathione catabolic process organic substance catabolic process cellular modified amino acid catabolic process	intracellular anatomical structure cytoplasm cellular anatomical entity cytosol

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C	IPR006840	Glutathione-specific gamma-glutamylcyclotransferase	Family
A, B, C	IPR036568	Gamma-glutamyl cyclotransferase-like superfamily	Homologous Superfamily
A, B, C	IPR013024	Gamma-glutamyl cyclotransferase-like	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C	Pharos: Q8WUX2	anorexia nervosa endogenous depression gastric carcinoma large cell medulloblastoma pancreatic ductal adenocarcinoma tuberculosis breast cancer exocrine pancreatic carcinoma hepatocellular carcinoma malignant pancreatic neoplasm psoriasis Crohn disease gastric cancer interstitial cystitis non-small cell lung carcinoma anorexia nervosa endogenous depression gastric carcinoma large cell medulloblastoma pancreatic ductal adenocarcinoma tuberculosis breast cancer exocrine pancreatic carcinoma hepatocellular carcinoma malignant pancreatic neoplasm psoriasis Crohn disease gastric cancer interstitial cystitis non-small cell lung carcinoma Sjogren syndrome

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.